Aligning Your Investment with Your Values

As a ministry of the UCC, we believe faith-based investing should align with the principles of the UCC. To accomplish this, we use a multilayered strategy that leverages corporate engagements, exclusionary screenings and proxy votings to influence companies, improve the world in which we live and deliver better long-term performance.

Our membership in the Interfaith Center on Corporate Responsibility allows us to engage companies through shareholder action and provide expert guidance on corporate best practices.

We initiate dialogues, submit shareholder resolutions, and collaborate with global organizations to steer companies in a more responsible and sustainable direction, ensure a safer long-term investment for our clients and create a better world for future generations.

The issues we discuss during corporate engagements include:

  • Operating within Humanitarian Rights Laws in International Zones of Conflict
  • Fair and sustainable lending practices
  • Access to healthcare and responsible domestic and global pharmaceutical pricing
  • Responsible oversight of opioid distribution
  • Aligning corporate executive compensation to sustainable practices
  • Urging heavy carbon emitters to plan for a 2-degree Celcius increase in atmospheric temperature

As a faith-based institutional investor, we favor securities of companies that demonstrate a commitment to promoting human health and dignity, environmental integrity and moral responsibility.

To ensure that the investment funds we offer continue to align with UCC teachings and the resolutions of General Synod, our screening policy excludes investments in companies with the following interests or characteristics:

  • Tobacco
  • Military and nuclear weapons
  • Coal and tar sands
  • Firearms
  • Private prison operation
  • Human rights violations, including in occupied territories
  • Negative environmental or greenhouse impact

We use proxy voting guidelines to encourage responsible corporate citizenship in the companies in which we invest. These guidelines represent our stance on environmental, labor and equality issues and demonstrate faithful stewardship of our investments.

Proxy voting enables UCF to have a substantial impact on protecting the financial performance and maximizing the long-term sustainability of the companies in which we invest and to deliver added value to our clients.

View our proxy voting disclosure page.

Economic Leverage

We use stock ownership to engage corporations in dialogue and promote shareholder action towards more sustainable, socially responsible activities.

Beyond Fossil Fuels

We lead the way in excluding certain companies paired with shareholder activism around climate issues by engaging in discussions and co-filing shareholder resolutions to effect meaningful change.

Supporting Sustainable Capitalism

As a leader in values-driven SRI investing, we aim to make sustainable capitalism possible. Through shareholder activism and collaboration with key players on global justice issue, we help companies forge new pathways towards responsible and sustainable operations – and create more opportunities to deliver greater long-term value to investors.

With sustainability becoming the new normal across every industry, and the impact of companies on society becoming more evident, UCF is proud to lead the charge in these efforts.

Our Investments

We provide a family of 11 traditional funds and three alternative funds that offer the performance and flexibility to meet your timeline, risk tolerance and return objectives.
Discover What's new

News and resources

AbbVie Shareholders Support Resolution on Link between Drug Price and Executive Pay

Today, 23.9% of voting shareholders of AbbVie, a U.S. pharmaceutical company, supported a United Church Funds-led shareholder resolution to report on the “feasibility of incorporating public concern over high drug price into the senior executive compensation arrangement.” 

UCF’s Shareholder Resolution for Gilead Sciences Receives 43.4% Support

United Church Funds is proud to have coordinated a shareholder resolution with Gilead Sciences, Inc. that received 43.4% support at Gilead’s annual general meeting on May 6, 2020. The resolution requested the company to separate the position of the Chair of the Board from the CEO position.

Investors Urge Pharma Companies to Work Collaboratively on COVID-19 Response

United Church Funds, along with investor members of the Interfaith Center on Corporate Responsibility, sent letters to the CEOs of 14 pharmaceutical companies, calling for a collaborative approach in the development of health technologies, including diagnostics, treatments and a vaccine in the global fight against COVID-19.